Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis-Reference-Cited by-同舟云学术

Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis

Published:2006 Issue:4 Volume:8 Page:R105
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Research & Therapy

Author:

Lequerré Thierry,Gauthier-Jauneau Anne-Christine,Bansard Carine,Derambure Céline,Hiron Martine,Vittecoq Olivier,Daveau Maryvonne,Mejjad Othmane,Daragon Alain,Tron François,Le Loët Xavier,Salier Jean-Philippe

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference31 articles.

1. A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

2. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trial

3. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

4. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

5. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Regulatory Challenges of Personalized Medicine;Cureus;2024-08-27

2. Towards Personalized Medicine in Rheumatoid Arthritis;Open Access Rheumatology: Research and Reviews;2024-05

3. Plasma Circular-RNA 0005567 as a Potential Marker of Disease Activity in Rheumatoid Arthritis;International Journal of Molecular Sciences;2023-12-28

4. DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis;Biomedicines;2023-07-13

5. Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs;Scientific Reports;2023-06-21